Usefulness of serum mass spectrometry to identify women diagnosed with higher grades of cervical intraepithelial neoplasia may differ by race

International Journal of Women's Health

Volumn 3, Issue 1, 2011, Pages 185-192

  Matthews, Roland ^a   Azuero, Andres ^b   Asmellash, Senait ^c   Brewster, Earl ^a   Partridge, Edward E ^b   Piyathilake, Chandrika J ^b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Cervical intraepithelial neoplasia; Race; Serum mass spectrometry

Indexed keywords

PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER GRADING; COLPOSCOPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPEAN AMERICAN; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PELVIC EXAMINATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU;

EID: 84055182495     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc. 2000;98:49-52.
2. Muir CS. Epidemiology, basic science, and the prevention of cancer: implications for the future. Cancer Res. 1990;50:6441-6448.
3. Forhan SE, Gottlieb SL, Sternberg MR, et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics. 2009;124:1505-1512.
4. Sun X W, Kuhn L, Ellerbrock T V, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodefciency virus. N Engl J Med. 1997;337:1343-1349.
5. Ferenczy A, Coutlee F, Franco E, Hankins C. Human papilloma-virus and HIV co-infection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ. 2003;169: 431-434.
6. Sroczynski G, Schnell-Inderst P, Mühlberger N. Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany. GMS Health Technol Assess. 27 Apr 2010;6:Doc05.
7. Piyathilake CJ, Oelschlager DK, Meleth MS, Partridge EE, Grizzle WE. plasma protein profles differ between women diagnosed with cervical intraepithelial neoplasia (CIN) 1 and 3. Cancer Informatics. 2007;2:345-349.
8. Piyathilake CJ, Macaluso M, Alvarez RD, Bell WC, Heimburger DC, Partridge EE. Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and suffcient vitamin B12 in the post-folic acid fortifcation era. Cancer Prev Res (Phila Pa). 2009;2:658-664.
9. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning. 2nd ed. New York: Springer-Verlag; 2009.
10. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. John Wiley & Sons, Inc: New York, NY; 2000.
11. Liu C, Pan C, Shen J, Wang H, Yong L. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer. Int J Med Sci. 2011;8:39-47.
12. Lin XL, Yang SY, Du J, et al. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-fight mass spectrometry serum protein profling. Chin Med J (Engl). 2010;123:34-39.
13. Qiu F, Liu HY, Dong ZN, Feng YJ, Zhang XJ, Tian Y P. Searching for potential ovarian cancer biomarkers with matrix-assisted laser desorption/ionization time-of-fight mass spectrometry. Am J Biomed Sci. 2009;1:80-90.
14. Pietrowska M, Marczak L, Polanska J, et al. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. J Transl Med. 2009;7:60.
15. Guo R, Pan C, Shen J, Liu C. New serum biomarkers for detection of esoph-ageal carcinoma using Matrix-assisted laser desorption/ ionization time-of-fight mass spectrometry. J Cancer Res Clin Oncol. 2011;137:513-519.
16. Liu C, Pan C, Shen J, Wang H, Yong L, Zhang R. Discrimination analysis of mass spectrometry proteomics for cervical cancer detection. Med Oncol. 2010 Nov 16. [Epub ahead of print].
17. Bosch FX, de Sanjose S. Chapter 1: human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr. 2003:3-13.
18. Matsumoto K, Oki A, Furuta R, et al; Japan HPV And Cervical Cancer (JHACC) Study Group. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J Cancer. 2010;128:2898-2910.
19. Kang WD, Oh MJ, Kim SM, Nam JH, Park CS, Choi HS. Signifcance of human papillomavirus genotyping with high-grade cervical intraepi-thelial neoplasia treated by a loop electrosurgical excision procedure. Am J Obstet Gynecol. 2010;203:72. e1-e6.
20. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008; 26(Suppl 10):K29-K41.
21. Einstein MH, Martens MG, Garcia FA, et al. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology. Gynecol Oncol. 2010;118:116-122.
22. Aldrich T, Hackley B. The impact of obesity on gynecologic cancer screening: an integrative literature review. J Midwifery Womens Health. 2010;55:344-356.
23. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson H W. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007;109:360-370.